Tumor necrosis factor alpha and beta and interferon gamma gene polymorphisms in turkish breast cancer patients

DNA and Cell Biology

Volumn 30, Issue 6, 2011, Pages 371-377

  Karakus, Nevin ^a   Kara, Nurten ^a   Ulusoy, Ali Naki ^a   Özaslan, Cihangir ^b   Bek, Yüksel ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; GAMMA INTERFERON; GENOMIC DNA; LYMPHOTOXIN; OLIGONUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC); VENOUS BLOOD;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON-GAMMA; LYMPHOTOXIN-ALPHA; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SEQUENCE ANALYSIS, DNA; TUMOR NECROSIS FACTOR-ALPHA; TURKEY;

EID: 79958238206     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2010.1113     Document Type: Article

References (47)

1. Azmy, I.A., Balasubramanian, S.P., Wilson, A.G., Stephenson, T.J., Cox, A., Brown, N.J., and Reed, M.W. (2004). Role of tumor necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res 6, 395-400.
2. Balkwill, F. (2002). Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13, 135-141. (Pubitemid 34229388)
3. Ben-Ari, Z., Mor, E., Papo, O., Kfir, B., Sulkes, J., Tambur, A.R, Tur-Kaspa, R, and Klein, T. (2003). Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 98, 144-150. (Pubitemid 36135183)
4. Chen, G, Wilson, R., Wang, S.H., Zheng, H.Z., Walker, J.J., and McKillop, J.H. (1996). Tumor necrosis factor alpha (TNF-a) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol 104, 154-159. (Pubitemid 26103423)
5. Chouchane, L., Ahmed, S.B., Baccouche, S., and Remadi, S. (1997). Polymorphism in the tumor necrosis factor-a promoter region and in the heat shock protein 70 genes associated with malignant tumors. Cancer 80, 1489-1496. (Pubitemid 27441024)
6. Daher, S., Shulzhenko, N., Morgun, A., Mattar, R., Rampim, G.F., Camano, L., and DeLima, M.G. (2003). Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 58, 69-77.
7. de Jong, M.M., Nolte, I.M., de Vries, E.G., Schaapveld, M., Kleibeuker, J.H., Oosterom, E., Oosterwijk, J.C., van der Hout, A.H., van der Steege, G., Bruinenberg, M., Boezen, H.M., Te Meerman, G.J., and van der Graaf, W.T. (2003). The HLA class III subregion is responsible for an increased breast cancer risk. Hum Mol Genet 12, 2311-2319. (Pubitemid 37160875)
8. de Kossodo, S., Moore, R., Gschmeissner, S., East, N., Upton, C., and Balkwill, F.R. (1995). Changes in the endogenous cyto-kines, adhesion molecules and platelets during cytokine-induced tumor necrosis. Br J Cancer 72, 1165-1172.
9. Gaudet, M.M., Egan, K.M., Lissowska, J., Newcomb, P.A., Brinton, L.A., Titus-Ernstoff, L., Yeager, M., Chanock, S., Welch, R., Peplonska, B., Trentham-Dietz, A., and Garcia-Closas, M. (2007). Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet 121, 483-490. (Pubitemid 46554685)
10. Giordani, I., Brazzi, P., Lasalandra, C., Quaranta, M., Schittulli, E., Della Ragione, E., and Iolascon, A. (2003). Polymorphisms of interleukin-10 and tumor necrosis factor-a gene promoter and breast cancer risk. Clin Chem 49, 1664-1667. (Pubitemid 37194223)
11. Gollob, J.A., Mier, J.W., Veenstra, K., Mc Dermott, D.F., Clancy, D., Clancy, M., and Atkins, M.B. (2000). Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response. Clin Cancer Res 6, 1678-1692. (Pubitemid 30305060)
12. Gonullu, G., Basturk, B., Evrensel, T., Oral, B., Gozkaman, A., and Manavoglu, O. (2007). Association of breast cancer and cytokine gene polymorphism in Turkish women. Saudi Med J 28, 1728-1733. (Pubitemid 350244364)
13. He, Y.-F., Wang, X.-H., Zhang, G.-M., Chen, H.-T., Zhang, H., and Feng, Z.-H. (2005). Sustained low-level expression of interferon-c promotes tumor development: potential insights in tumor prevention and tumor immunotherapy. Cancer Immunol Immunother 54, 891-897. (Pubitemid 40991331)
14. Hollegaard, M.V., and Bidwell, J.L. (2006). Cytokine gene polymorphism in human disease: on-line databases, Supplement 3. Genes Immun 7, 269-276. (Pubitemid 43871527)
15. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., and Thun, M.J. (2008). Cancer statistics, 2008. CA Cancer J Clin 58, 71-96. (Pubitemid 351521864)
16. Kamali-Sarvestani, E., Gharesi-Fard, B., Sarvari, J., and Talei, A.A.R. (2005a). Association of TNF-a and TNF-b gene polymorphisms with steroid receptor expression in breast cancer patients. Pathol Oncol Res 11, 99-102. (Pubitemid 41039446)
17. Kamali-Sarvestani, E., Merat, A., and Talei, A.R. (2005b). Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-a and TNF-b) and gamma interferon (IFN-c) among Iranian women with breast cancer. Cancer Lett 223, 113-119. (Pubitemid 40693715)
18. Kawatsu, M., Funabashi, I., Kajikawa, T., Takeo, K., Asahi, T., Yamashita, T., Kawaharada, H., and Watanabe, K. (1990). Synergistic anti-tumor effect of glycosylated recombinant human lymphotoxin with human interferon gamma on lym-photoxin-sensitive human tumor. J Interferon Res 10, 519-529. (Pubitemid 20351007)
19. Kirchhoff, S., and Hauser, H. (1999). Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 result in apoptosis. Oncogene 18, 3725-3736. (Pubitemid 29338505)
20. Kirkpatrick, A., Bidwell, J., van der Brule, A.J., Meijer, C.J., Pawade, J., and Glew, S. (2004). TNF alpha polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 92, 675-679. (Pubitemid 38183162)
21. Kohaar, I., Tiwari, P., Kumar, R., Nasare, V., Thakur, N, Das, B.C., and Bharadwaj, M. (2009). Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population. Breast Cancer Res Treat 114,347-355.
22. Kroeger, K.M., Carville, K.S., and Abraham, L.J. (1997). The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34, 391-399. (Pubitemid 27368335)
23. Lee, K.-M., Park, S.K., Hamajima, N, Tajima, K., Yoo, K.-Y., Shin, A., Noh, D.-Y., Ahn, S.-H., Hirvonen, A., and Kang, D. (2005). Genetic polymorphisms of TGF1 and TNF and breast cancer risk. Breast Cancer Res Treat 90, 149-155. (Pubitemid 40568898)
24. Lester, J. (2007). Breast cancer in 2007: incidence, risk assessment and risk reduction strategies. Clin J Oncology Nursing 11, 619-622.
25. Lio, D., Marino, V., Scrauto, A., Gioia, V., Scola, L., Crivello, A., Forte, G.I., Colonna-Romano, G, Candore, G, and Caruso, C. (2002). Genotype frequencies of the +874 T-A single nucleotide polymorphism in the first intron of the interferon-y gene in a sample of Sicilian patients affected by tuberculosis. Eur J Im-munogenet 29, 371-374. (Pubitemid 35177197)
26. Messer, G, Spangler, U., Jung, M.C., Honold, G, Blomer, K., Pape, G.R., Riethmuller, G, and Weiss, E.H. (1991). Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 173,209-219.
27. Mestiri, S., Bouaouina, N, Ahmed, S.B., Khedhaier, A., Jrad, B.B., Remadi, S., and Chouchane, L. (2001). Genetic variation in the tumor necrosis factor-a promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer 91, 672-678. (Pubitemid 32173290)
28. Miller, S.A., Dykes, D.D., and Polesky, H.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215.
29. Onay, V.U., Briollais, L., Knight, J.A., Shi, E., Wang, Y., Wells, S., Li, H., Rajendram, I., Andrulis, I.L., and Ozcelik, H. (2006). SNP-SNP interactions in breast cancer susceptibility. BMC Cancer 6, 114-129.
30. Ostashkin, A.S., Malivanova, T.F., Iurchenko, V.A., and Ma-zurenko, N.N. (2008). Tumor necrosis factor gene polymorphisms in breast cancer patients. Genetika 44, 1275-1280.
31. Ozaki, K, Ohnishi, Y., Iida, A., Sekine, A., Yamada, R., Tsunoda, T., Sato, H., Sato, H., Hori, M., Nakamura, Y., and Tanaka, T. (2002). Functional SNPs in the lymphotoxin-a gene that are associated with susceptibility to myocardial infarction. Nat Genet 32, 650-654. (Pubitemid 35435179)
32. Ozzelo, L., de Rosa, CM., Cantell, K, Kauppinen, H.L., and Habif, D.V. (1995). Regression of human breast cancer xenografts in response to intralesional treatment with interferons alpha and gamma potentiated by tumor necrosis factor. J Interferon Cytokine Res 15, 839-848.
33. Park, K.S., Mok, J.W., Ko, H.E., Tokunagat, K, and Lee, M.H. (2002). Polymorphisms of tumor necrosis factors A and B in breast cancer. Eur J Immunogenet 29, 7-10. (Pubitemid 34146653)
34. Pennica, D., Nedwin, G, Hayflick, J., Seeburg, P.H., Derynck, R., Palladino, M.A., Kohr, W.J., Aggarwal, B.B., and Goeddel, D.V. (1984). Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312, 724-729. (Pubitemid 15195918)
35. Pravica, V., Perrey, C, Stevens, A., Lee, J.H., and Hutchinson, I.V. (2000). A single nucleotide polymorphism in the first intron of the human gene: absolute correlation with a polymorphic CA microsatellite marker of high interferon production. Hum Immunol 61, 863-866.
36. Rossouw, M., Nel, H.J., Cooke, G.S., van Helden, P.D., and Hoal, E.G. (2003). Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 361, 1871-1872. (Pubitemid 36645185)
37. Ruiz-Ruiz, C, Munoz-Pinedo, C, and Lopez-Rivas, A. (2000). Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program. Cancer Res 60, 5673-5680.
38. Scola, L., Vaglica, M., Crivello, A, Palmeri, L., Forte, G.I., Maca-luso, M.C., Giacalone, A., Noto, L.D., Bongiovanni, A, Rai-mondi, C, Accardo, A., Verna, R., Candore, G, Caruso, C, Lio, D., and Palmeri, S. (2006). Cytokine gene polymorphisms and breast cancer susceptibility. Ann N Y Acad Sci 1089, 104-109. (Pubitemid 47092072)
39. Smith, CA. (1994). The TNF receptor super family of cellular and viral proteins-activation, co stimulation and death. Cell 76, 959-962. (Pubitemid 24106376)
40. Smith, K.C, Bateman, A.C., Fussell, H.M., and Howell, W.M. (2004). Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Imunogenet 31, 167-173. (Pubitemid 39049861)
41. Stark, GR, Kerr, I.M., Williams, B.R, Silverman, R.H., and Schreiber, R.D. (1998). How cells respond to interferons. Annu Rev Bichem 67, 227-264. (Pubitemid 28411130)
42. Sunpaweravong, S., and Sunpaweravong, P. (2005). Recent developments in critical genes in the molecular biology of breast cancer. Asian J Surg 28, 71-75. (Pubitemid 40314600)
43. Tegoshi, H, Hasegawa, G, Obayashi, H, Nakano, K, Kitagawa, Y., Fukui, M., Matsuo, S., Deguchi, M., Ohta, M., Nishimura, M., Nakamura, N, and Yoshikawa, T. (2002). Polymorphisms of interferon-gamma gene CA-repeat and interleukin-10 promoter region (-592A/C) in Japanese type I diabetes. Hum Immunol 63, 121-128. (Pubitemid 34132588)
44. Weber, B.L., and Nathanson, K.L. (2000). Low penetrance genes associated with increased risk for breast cancer. Eur J Cancer 36, 1193-1199. (Pubitemid 30407005)
45. Whichelow, C.E., Hitman, G.A., Raafat, I., Bottazzo, G.F., and Sachs, J.A. (1996). The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls. Eur J Immunogenet 23, 425-435. (Pubitemid 26413574)
46. Wilson, A.G, di Giovine, F.S., Blakemore, A.I.F., and Duff, GW. (1992). Single base polymorphism in the human tumor necrosis factor alpha (TNF-a) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1, 353.
47. Wilson, A.G, Symons, J.A., McDowell, T.L., McDevitt, H.O., and Duff, GW. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94, 3195-3199. (Pubitemid 27157287)